Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
3
×
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
3
×
clinical trials
detroit blog main
detroit top stories
drugs
3
×
fda
3
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
deals
investing
merck
roche
startups
4d molecular therapeutics
abbvie
acne
acute myeloid leukemia
What
fda
3
×
approved
bio
drug
roundup
ahead
asco
branded
cancer
choices
commissioner
companies
consumers
costly
counterweight
deeper
digital
disease
dna
drugs
elevatebio
epidemic
fatty
fingerprint
frenzied
generic
genetic
going
graft
growing
known
led
liver
matter
medications
medicine
merck
nash
nd
new
Language
Current search:
fda
×
drugs
×
fda
×
" boston blog main "
×
cancer
×
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues